Drug search by name

Carbamazepine Extended-Release Capsules (Carbatrol) and Blood dyscrasias

Result of checking the interaction of drug Carbamazepine Extended-Release Capsules (Carbatrol) and disease Blood dyscrasias for safety when used together.

Check result:

Carbamazepine Extended-Release Capsules (Carbatrol) <> Blood dyscrasias

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of carbamazepine has been associated with hematologic toxicities such as leukopenia, neutropenia, thrombocytopenia and, rarely, aplastic anemia and agranulocytosis. Carbamazepine should not be used in patients with history of bone marrow depression. Complete blood counts, including platelets and possibly reticulocytes and serum iron, should be performed prior to initiating therapy and regularly during therapy. Patients who exhibit decreases in blood counts at any time during treatment should be monitored more closely. Marked depression of blood counts may be indication for permanent withdrawal of carbamazepine therapy.

References:

Tohen M, Castillo J, Cole JO, et al "Thrombocytopenia associated with carbamazepine: a case series." J Clin Psychiatry 52 (1991): 496-8
Stroink AR, Skillrud DM, Kiely JM, Sundt TM Jr "Carbamazepine-induced hemolytic anemia." Acta Haematol 72 (1984): 346-8
"Product Information. Tegretol (carbamazepine)." Novartis Pharmaceuticals, East Hanover, NJ.
Ponte CD "Carbamazepine-induced thrombocytopenia, rash, and hepatic dysfunction." Drug Intell Clin Pharm 17 (1983): 642-4
Terao T "Transient thrombocytopenia while continuing carbamazepine." Am J Psychiatry 150 (1993): 1750-1
Rush JA, Beran RG "Leucopenia as an adverse reaction to carbamazepine therapy." Med J Aust 140 (1984): 426-8
Pellock JM "Carbamazepine side effects in children and adults." Epilepsia 28 (1987): s64-70
Schweiger FJ, Kelton JG, Messner H, et al "Anticonvulsant-induced marrow suppression and immune thrombocytopenia." Acta Haematol 80 (1988): 54-8
Hawson GA, Bain BJ, Whyte I "Agranulocytosis after administration of carbamazepine." Med J Aust Jan (1980): 82-3
Baciewicz G, Yerevanian BI "Thrombocytopenia associated with carbamazepine: case report and review." J Clin Psychiatry 45 (1984): 315-6
Sobotka JL, Alexander B, Cook BL "A review of carbamazepine's hematologic reactions and monitoring recommendations." DICP 24 (1990): 1214-9
Shoenfeld Y, Ben Baruch N, Livni E, et al "Carbamazepine (tegretol)-induced thrombocytopenia." Acta Haematol 68 (1982): 74
Medberry CA, Pappas AA, Ackerman BH "Carbamazepine and erythroid arrest." Drug Intell Clin Pharm 21 (1987): 439-41
Terao T "Reticulocyte increase and carbamazepine." Am J Psychiatry 150 (1993): 1271-2